APA (7th ed.) Citation

Zhang, C., Wang, J., Wang, X., Meng, Z., Cheng, Y., & Li, K. (2022). Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer. China Anti-Cancer Association.

Chicago Style (17th ed.) Citation

Zhang, Cuicui, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng, and Kai Li. Peripheral Blood Indices to Predict PFS/OS with Anlotinib as a Subsequent Treatment in Advanced Small-cell Lung Cancer. China Anti-Cancer Association, 2022.

MLA (9th ed.) Citation

Zhang, Cuicui, et al. Peripheral Blood Indices to Predict PFS/OS with Anlotinib as a Subsequent Treatment in Advanced Small-cell Lung Cancer. China Anti-Cancer Association, 2022.